Lycia Therapeutics, Inc. Common Stock（LYCA）價格預測LYCALycia Therapeutics, Inc. Common Stock

Lycia Therapeutics, Inc. is currently trading at $27.18, which is 49.6% of its 52-week range. While the stock has shown a strong year-to-date increase of 51%, it has recently declined by 5.79% over the past five days. The lack of a P/E ratio and high price-to-sales ratio of 310.1 indicate potential overvaluation concerns. The main risk is the recent decline in IPO activity, which may affect market sentiment and investor confidence.

Lycia Therapeutics, Inc. Common Stock (LYCA) last closed at $27.1800003, gaining +2.95%. These facts feed the 1-day and 1-week LYCA price prediction above.